- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07632781
THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT
THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSIVE CARE PATIENTS UNDER MECHANICAL VENTILATION SUPPORT ON PAIN AND PHYSIOLOGICAL PARAMETERS.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Mechanical ventilation (MV), one of the most common treatment methods in Intensive Care Units (ICUs), is a critical treatment approach to ensure adequate respiratory function in patients.
Although mechanical ventilation is a life-saving treatment method in ICUs, it can cause many physiological and psychological problems for patients. Furthermore, excessive exposure to physical, psychosocial, and environmental stressors can affect the patient's autonomic response and vital parameters (tachycardia, hypertension, tachypnea), leading to hemodynamic instability
The World Health Organization (WHO) defines Integrated, Complementary, and Alternative Medicine Practices as the provision of healthcare services that are not part of a country's own tradition or conventional medicine and are not fully integrated into the dominant healthcare system In intensive care patients, non-pharmacological methods such as aromatherapy, music therapy, massage, reflexology, acupressure, and Reiki are used as complementary and alternative treatments. Su Jok, one of these non-pharmacological methods, is an alternative treatment method based on traditional Korean medicine. Su Jok is a treatment method that uses the feet and hands, derived from the Korean words Su (hand) and Jok (foot). In the literature, it is argued that nurses can apply Su Jok therapy as an integrative method in symptom management due to its simplicity of application, lack of side effects, and non-invasiveness, which is similar to the philosophy of integrative nursing. Looking at the literature, very few studies on Su Jok therapy have been found. No studies have been found in the literature regarding the effect of Su Jok therapy on intensive care patients and patients on mechanical ventilation support.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Kahramanmaraş
-
Kahramanmaraş, Kahramanmaraş, Turquia (Türkiye), 46050
- Kahramanmaraş
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
Patients who are in intensive care,
- Patients receiving IMV support,
- Patients who were admitted to the ICU from the start date of the study and are planned to be monitored for at least 24 hours,
- Patients without any problems in the area where Su-Jok will be applied,
- Patients with GCS > 3, RASS between +1 and +4, BPS > 3
Exclusion Criteria:
• Patients in the ward,
- Patients with any problems such as fungal infections or wounds in the area where Su Jok will be applied,
- Patients with a GCS of 3,
- Patients not receiving IMV support will not be included in the study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Grupo de controle
Nenhuma intervenção será aplicada ao grupo controle.
|
|
|
Experimental: Intervetion group
In the intervention group, su-jok seed therapy will be applied to the su-jok reflection zones on the hands.
|
In the intervention group, the reflex zones on the hands were identified with a probe.
Buckwheat seeds were fixed to these areas with adhesive tape and massaged.
The seeds remained in place for 4 hours.
After 2 hours, these areas were stimulated with a 1-2 minute massage.
Measurements were recorded on a data collection form.
The application was carried out for 3 days.
|
|
Comparador de Placebo: Placebo group
In the placebo group, su-jok seed therapy will be applied to areas on the hands that are different from the reflection zones.
|
In the placebo group, reflex zones on the hand were identified using a probe.
Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged.
The seeds remained in place for 4 hours.
After 2 hours, these areas were stimulated with a 1-2 minute massage.
Measurements were recorded on a data collection form.
The application was carried out for 3 days.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Systolic Blood Pressure
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Hemodynamic response measured by systolic blood pressure
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Heart Rate (Pulse Rate)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Heart rate measured in beats per minute
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Oxygen Saturation (SpO₂)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Peripheral oxygen saturation
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Body Temperature
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Core body temperature
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Respiratory Rate
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Number of breaths per minute
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Richmond Agitation-Sedation Scale (RASS)
Prazo: baseline, 1 hour, 4 hours after intervention
|
Negative scores indicate sedation, positive scores indicate agitation
|
baseline, 1 hour, 4 hours after intervention
|
|
Behavioral Pain Scale (BPS)
Prazo: baseline, 1 hour, 4 hours after intervention
|
Higher scores indicate more severe pain
|
baseline, 1 hour, 4 hours after intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Hemodynamic Stability Index (Systolic/Diastolic Blood Pressure Change)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Change in systolic and diastolic blood pressure from baseline to post-intervention measurements.
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Oxygenation Trend (SpO₂ Change Over Time)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
hanges in peripheral oxygen saturation over the intervention period.
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Heart Rate Variability (Clinical Pulse Trend)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Changes in heart rate measured in beats per minute during and after intervention.
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Sedation-Agitation Level Stability (RASS Trend)
Prazo: baseline, 1 hour, 4 hours after intervention
|
Changes in Richmond Agitation-Sedation Scale (RASS) scores over time indicating sedation or agitation level.
|
baseline, 1 hour, 4 hours after intervention
|
|
Pain Intensity Change (Behavioral Pain Scale Trend)
Prazo: baseline, 1 hour, 4 hours after intervention
|
Changes in Behavioral Pain Scale (BPS) scores indicating pain severity over time.
|
baseline, 1 hour, 4 hours after intervention
|
|
Respiratory Stability (Respiratory Rate Change)
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
Changes in respiratory rate indicating respiratory stability during intervention.
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Temperature Stability
Prazo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
hanges in body temperature over time following intervention.
|
baseline, 15 minutes, 60 minutes, 4 hours after intervention
|
|
Non-pharmacological Intervention Effectiveness (Overall Clinical Stability Score)
Prazo: baseline, 4 hours after intervention
|
Composite assessment of physiological stability based on vital signs and sedation/pain scores.
|
baseline, 4 hours after intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: NERMİN OLGUN, Prof. Dr., Hasan Kalyoncu University
- Investigador principal: MELTEM KALAYCI, Hasan Kalyoncu University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HKU-LEE-MK-01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .